Health Technology, Digital Healthcare

HCA Healthcare Partnership with American Heart Association

Steven Manoukian, MD, FAHA, FACC, FSCAI, Senior Vice President of Strategic Service Lines at HCA Healthcare on the link between cardiology and stroke management and how HCA Healthcare is teaming up with the American Heart Association in leading the charge on this important issue in Florida and across the nation.

Spotlight

USV PRIVATE LIMITED

We are a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India. We market our products globally to 75 countries. In the financial year 2015-16, our total income was Rs 25,445 million. Our Indian business contributed 82% to the revenue and the rest was from export of APIs and Finished Dosages. In India we are recognised for our leadership in the Oral Anti-Diabetic market where we rank No. 1 by Rx and Value. In the Cardiovascular diseases segment we are No. 1 by Rx and rank no. 6 by Value . We also have a significant presence in the areas of Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS.

OTHER VIDEOS

Centralizing your organization's healthcare data

video | September 11, 2023

Your healthcare organization needs a centralized, trustworthy data asset. Top health systems and health plans partner with Arcadia to drive ROI, improve workflows, and operationalize insights across their growing Medicare Advantage, MSSP, and commercial populations....

Watch Now

Accelerate Breakthroughs in Health Care and Life Sciences with SAS

video | September 6, 2023

The answers to the world’s toughest health care challenges are in the data. SAS helps customers bring together a complex ecosystem of health care and life sciences data, accelerate insights and improve lives. Let’s find your next breakthrough....

Watch Now

FASTlab HPLC+

video | September 7, 2023

Learn more about the new FASTlab HPLC+. Efficient HPLC purification and reformulation in one. Increased flexibility and efficiency of R&D tracer production enabling nearly all compounds and synthesis methods. Integrated reformulation system enabling higher dilution volume and faster mixing to empower your clinical research....

Watch Now

Digital Healthcare for Remote Communities

video | September 8, 2023

The University of Galway is bringing 5G connectivity to Clare Island in Ireland, improving digital inclusion and access to quality care....

Watch Now

Spotlight

USV PRIVATE LIMITED

We are a 55 year old leading healthcare company which began as a joint venture with USV&P Inc. USA, a subsidiary of Revlon. Our product offering today includes Active Pharmaceutical Ingredients (APIs), Fixed Dosages Formulations (FDF), Peptides, Biosimilars and Injectables. These are manufactured in our cGMP compliant plants located in India. We market our products globally to 75 countries. In the financial year 2015-16, our total income was Rs 25,445 million. Our Indian business contributed 82% to the revenue and the rest was from export of APIs and Finished Dosages. In India we are recognised for our leadership in the Oral Anti-Diabetic market where we rank No. 1 by Rx and Value. In the Cardiovascular diseases segment we are No. 1 by Rx and rank no. 6 by Value . We also have a significant presence in the areas of Vitamins, Minerals, Nutrients, Dermatology, Gastroenterology and CNS.

Events